Article abstract
Nature Cell Biology 9, 755 - 764 (2007)
Published online: 18 June 2007 | doi:10.1038/ncb1602
BACE1 regulates voltage-gated sodium channels and neuronal activity
Doo Yeon Kim1,5, Bryce W. Carey1,5, Haibin Wang2, Laura A. M. Ingano1, Alexander M. Binshtok2, Mary H. Wertz1, Warren H. Pettingell1, Ping He3, Virginia M.-Y. Lee4, Clifford J. Woolf2 & Dora M. Kovacs1
Abstract
BACE1 activity is significantly increased in the brains of Alzheimer's disease patients, potentially contributing to neurodegeneration. The voltage-gated sodium channel (Nav1)
2-subunit (
2), a type I membrane protein that covalently binds to Nav1
-subunits, is a substrate for BACE1 and
-secretase. Here, we find that BACE1–
-secretase cleavages release the intracellular domain of
2, which increases mRNA and protein levels of the pore-forming Nav1.1
-subunit in neuroblastoma cells. Similarly, endogenous
2 processing and Nav1.1 protein levels are elevated in brains of BACE1-transgenic mice and Alzheimer's disease patients with high BACE1 levels. However, Nav1.1 is retained inside the cells and cell surface expression of the Nav1
-subunits and sodium current densities are markedly reduced in both neuroblastoma cells and adult hippocampal neurons from BACE1-transgenic mice. BACE1, by cleaving
2, thus regulates Nav1
-subunit levels and controls cell-surface sodium current densities. BACE1 inhibitors may normalize membrane excitability in Alzheimer's disease patients with elevated BACE1 activity.
- Neurobiology of Disease Laboratory, Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA.
- Neural Plasticity Research Group, Department of Anaesthesia and Critical Care, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.
- Haldeman Laboratory of Molecular and Cellular Neurobiology, Sun Health Research Institute, Sun City, AZ 85351, USA.
- Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, PA 19104, USA.
- These authors contributed equally to this work.
Correspondence to: Dora M. Kovacs1 e-mail: dora_kovacs@hms.harvard.edu
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Alzheimer's disease A firm base for drug developmentNature News and Views (02 Dec 1999)
Does Alzheimer disease tilt the scales of amyloid degradation versus accumulation?Nature Medicine News and Views (01 Feb 2000)
See all 4 matches for News And ViewsRESEARCH
JAZ repressor proteins are targets of the SCF COI1 complex during jasmonate signallingNature Article (09 Aug 2007)
See all 53 matches for Research
